You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2025

Drug Price Trends for MULTIVIT-IRON-FL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MULTIVIT-IRON-FL

Average Pharmacy Cost for MULTIVIT-IRON-FL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MULTIVIT-IRON-FLUOR 0.25 MG/ML 61269-0163-50 0.19536 ML 2025-06-18
MULTIVIT-IRON-FLUOR 0.25 MG/ML 61269-0163-50 0.19484 ML 2025-05-21
MULTIVIT-IRON-FLUOR 0.25 MG/ML 61269-0163-50 0.19767 ML 2025-04-23
MULTIVIT-IRON-FLUOR 0.25 MG/ML 61269-0163-50 0.20033 ML 2025-03-19
MULTIVIT-IRON-FLUOR 0.25 MG/ML 61269-0163-50 0.20335 ML 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Multivitamins with Iron

Last updated: January 2, 2025

Introduction to Multivitamins with Iron

Multivitamins with iron are dietary supplements designed to address nutritional deficiencies, particularly iron deficiency and anemia. These supplements are essential for various bodily functions, including oxygen transport, energy metabolism, and DNA synthesis.

Global Market Overview

The global market for iron supplements, which includes multivitamins with iron, is growing steadily due to several key factors.

  • Prevalence of Iron Deficiency: The high prevalence of iron deficiency and anemia worldwide is a significant driver for the market. According to market research, the global iron supplements market was valued at USD 6,218.5 million in 2023 and is expected to reach USD 9,293.8 million by 2033, growing at a CAGR of 4.1% from 2024 to 2033[3].

  • Rising Health Awareness: Increasing awareness about the importance of iron in maintaining overall health and preventing anemia contributes to market growth. Individuals are seeking preventive healthcare measures and dietary supplements, driving the demand for multivitamins with iron[3].

Market Segmentation

By Type of Iron Supplement

The market for iron supplements, including multivitamins with iron, can be segmented by the type of iron used. Common types include:

  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose (FCM)
  • Others

FCM has emerged as a leading segment due to its effectiveness, safety, and cost-efficiency. It is preferred for its high-dose iron replenishment capabilities and is used for treating various forms of anemia[1][4].

By Application

Multivitamins with iron are used in various applications:

  • Chronic Kidney Disease (CKD)
  • Inflammatory Bowel Disease (IBD)
  • Cancer
  • Other Diseases

The CKD segment accounts for a significant revenue share due to the frequent need for iron therapy in patients with CKD[1][4].

Regional Market Analysis

North America

North America holds the largest market share for intravenous iron drugs and is expected to continue its dominance. The U.S. market is driven by the increasing prevalence of anemia, with over 3 million people affected, and the approval of new IV iron drugs such as INJECTAFER for specific conditions like heart failure[1][4].

Europe

Europe is the second-largest market, driven by factors such as the presence of major market players, the development and commercialization of new drugs, and the rising incidence of cancer. Germany dominates the regional market due to high healthcare expenditures and the high prevalence of cancer[1].

Asia Pacific

The Asia Pacific region is expected to witness the fastest growth due to the increasing prevalence of chronic diseases like CKD, IBD, and cancer, which frequently result in iron deficiency anemia (IDA)[1][4].

Latin America

Latin America, particularly countries like Brazil and Mexico, is identified as a lucrative region. The dynamic economies, R&D activities, and rapid technological advancements in these countries are expected to drive market growth[1].

Price Projections and Trends

Current Pricing

The cost for multivitamins with iron can vary based on the formulation and brand. For example, a multivitamin with iron and fluoride oral liquid can cost around $15.90 for a 50-milliliter supply[2].

Future Pricing Trends

The market for iron supplements, including multivitamins with iron, is expected to grow steadily. However, pricing trends may be influenced by several factors:

  • Technological Advancements: Innovations in drug delivery systems, such as nanoparticle-based formulations, could enhance the efficacy and reduce the cost of these supplements[1].
  • Regulatory Approvals: New product launches and approvals, such as the FDA approval of INJECTAFER, can impact pricing by increasing competition and driving down costs[1][4].
  • Market Competition: The entry of new players and the expansion of existing ones can lead to competitive pricing strategies, potentially reducing the cost of multivitamins with iron[3].

Key Drivers and Challenges

Drivers

  • Increasing Prevalence of Chronic Diseases: The growing prevalence of CKD, IBD, and cancer drives the demand for effective anemia management solutions, including multivitamins with iron[1][4].
  • Advancements in Technology: Improvements in drug delivery systems and the development of biocompatible materials enhance the precision and reliability of iron therapy administration[1].
  • Regulatory Approvals: New product approvals and launches are critical for market expansion and can drive growth by providing more treatment options[1][4].

Challenges

  • Side Effects and Adverse Reactions: Despite advancements, some iron supplements can have side effects, which may deter some consumers. However, formulations like FCM have shown superior performance with fewer adverse effects[1].
  • Economic Factors: The cost of these supplements can be a barrier for some consumers, especially in regions with lower healthcare expenditures[2].

Expert Insights and Statistics

  • Ferric Carboxymaltose (FCM) Efficacy: FCM has been proven to be safer and more effective compared to other IV iron drugs. For instance, a report published by NCBI in June 2022 highlighted that FCM can treat moderate-to-severe anemia in around 4 weeks[1].
<blockquote>
"FCM has greater efficacy with respect to improving hemoglobin levels and results in limited adverse events." - NCBI Report, June 2022[1].
</blockquote>
  • Market Growth Statistics: The global intravenous iron drugs market, which includes multivitamins with iron, is expected to grow at a CAGR of 9.2% from 2024 to 2030, reaching USD 5.62 billion by 2030[1].

Key Takeaways

  • The global market for iron supplements, including multivitamins with iron, is driven by the increasing prevalence of chronic diseases and advancements in technology.
  • Ferric carboxymaltose (FCM) is a leading segment due to its safety and efficacy.
  • North America and Europe are significant markets, with the Asia Pacific region expected to grow the fastest.
  • Pricing trends will be influenced by technological advancements, regulatory approvals, and market competition.

Frequently Asked Questions (FAQs)

1. What is the current market size for intravenous iron drugs? The global intravenous iron drugs market size was estimated at USD 3.03 billion in 2023[1].

2. What is the expected growth rate for the intravenous iron drugs market? The market is expected to grow at a CAGR of 9.2% from 2024 to 2030[1].

3. Which region dominates the intravenous iron drugs market? North America holds the largest market share, primarily due to the increasing approvals and launch of new IV drugs in the U.S.[1].

4. What are the key applications of multivitamins with iron? Key applications include treating chronic kidney disease, inflammatory bowel disease, cancer, and other diseases[1][4].

5. How does ferric carboxymaltose (FCM) compare to other IV iron drugs? FCM has greater efficacy in improving hemoglobin levels and results in limited adverse events, making it a safer and more effective option[1].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.